361 related articles for article (PubMed ID: 20739337)
1. Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6.
Uzawa A; Mori M; Arai K; Sato Y; Hayakawa S; Masuda S; Taniguchi J; Kuwabara S
Mult Scler; 2010 Dec; 16(12):1443-52. PubMed ID: 20739337
[TBL] [Abstract][Full Text] [Related]
2. CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis.
Narikawa K; Misu T; Fujihara K; Nakashima I; Sato S; Itoyama Y
J Neuroimmunol; 2004 Apr; 149(1-2):182-6. PubMed ID: 15020078
[TBL] [Abstract][Full Text] [Related]
3. Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.
Matsushita T; Tateishi T; Isobe N; Yonekawa T; Yamasaki R; Matsuse D; Murai H; Kira J
PLoS One; 2013; 8(4):e61835. PubMed ID: 23637915
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis.
Ishizu T; Osoegawa M; Mei FJ; Kikuchi H; Tanaka M; Takakura Y; Minohara M; Murai H; Mihara F; Taniwaki T; Kira J
Brain; 2005 May; 128(Pt 5):988-1002. PubMed ID: 15743872
[TBL] [Abstract][Full Text] [Related]
5. Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica.
Wang H; Wang K; Zhong X; Dai Y; Qiu W; Wu A; Hu X
Neuroimmunomodulation; 2012; 19(5):304-8. PubMed ID: 22777162
[TBL] [Abstract][Full Text] [Related]
6. Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis.
Uzawa A; Mori M; Ito M; Uchida T; Hayakawa S; Masuda S; Kuwabara S
J Neurol; 2009 Dec; 256(12):2082-4. PubMed ID: 19655191
[TBL] [Abstract][Full Text] [Related]
7. Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6.
Wei Y; Chang H; Li X; Wang H; Du L; Zhou H; Xu W; Ma Y; Yin L; Zhang X
Neuroimmunomodulation; 2018; 25(4):215-224. PubMed ID: 30544111
[TBL] [Abstract][Full Text] [Related]
8. Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis.
Wang KC; Lee CL; Chen SY; Chen JC; Yang CW; Chen SJ; Tsai CP
J Interferon Cytokine Res; 2013 Feb; 33(2):58-64. PubMed ID: 23398365
[TBL] [Abstract][Full Text] [Related]
9. Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients.
Içöz S; Tüzün E; Kürtüncü M; Durmuş H; Mutlu M; Eraksoy M; Akman-Demir G
Int J Neurosci; 2010 Jan; 120(1):71-5. PubMed ID: 20128675
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid high-mobility group box protein 1 in neuromyelitis optica and multiple sclerosis.
Wang H; Wang K; Wang C; Xu F; Zhong X; Qiu W; Hu X
Neuroimmunomodulation; 2013; 20(2):113-8. PubMed ID: 23328212
[TBL] [Abstract][Full Text] [Related]
11. Markedly elevated soluble intercellular adhesion molecule 1, soluble vascular cell adhesion molecule 1 levels, and blood-brain barrier breakdown in neuromyelitis optica.
Uzawa A; Mori M; Masuda S; Kuwabara S
Arch Neurol; 2011 Jul; 68(7):913-7. PubMed ID: 21747031
[TBL] [Abstract][Full Text] [Related]
12. High CSF neurofilament heavy chain levels in neuromyelitis optica.
Miyazawa I; Nakashima I; Petzold A; Fujihara K; Sato S; Itoyama Y
Neurology; 2007 Mar; 68(11):865-7. PubMed ID: 17353477
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases.
Ichinose K; Arima K; Ushigusa T; Nishino A; Nakashima Y; Suzuki T; Horai Y; Nakajima H; Kawashiri SY; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Motomura M; Kawakami A
Clin Immunol; 2015 Apr; 157(2):114-20. PubMed ID: 25656641
[TBL] [Abstract][Full Text] [Related]
14. Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.
Chang KH; Tseng MY; Ro LS; Lyu RK; Tai YH; Chang HS; Wu YR; Huang CC; Hsu WC; Kuo HC; Chu CC; Chen CM
Clin Chim Acta; 2013 Feb; 417():26-30. PubMed ID: 23262373
[TBL] [Abstract][Full Text] [Related]
15. Correlation between serum thyroxine and complements in patients with multiple sclerosis and neuromyelitis optica.
Zhang B; Jiang Y; Yang Y; Peng F; Hu X
Neuro Endocrinol Lett; 2008 Apr; 29(2):256-60. PubMed ID: 18404143
[TBL] [Abstract][Full Text] [Related]
16. Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis.
Li Y; Wang H; Long Y; Lu Z; Hu X
J Neuroimmunol; 2011 May; 234(1-2):155-60. PubMed ID: 21489641
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.
Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X
Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400
[TBL] [Abstract][Full Text] [Related]
18. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.
Uzawa A; Mori M; Uchida T; Masuda H; Ohtani R; Kuwabara S
Clin Chim Acta; 2016 Jan; 453():131-3. PubMed ID: 26686775
[TBL] [Abstract][Full Text] [Related]
20. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]